These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
782 related articles for article (PubMed ID: 29196053)
1. Centchroman regulates breast cancer angiogenesis via inhibition of HIF-1α/VEGFR2 signalling axis. Dewangan J; Kaushik S; Rath SK; Balapure AK Life Sci; 2018 Jan; 193():9-19. PubMed ID: 29196053 [TBL] [Abstract][Full Text] [Related]
2. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells. Chen MC; Lee CF; Huang WH; Chou TC Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116 [TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis. Lim HN; Jang JP; Han JM; Jang JH; Ahn JS; Jung HJ Molecules; 2018 Mar; 23(3):. PubMed ID: 29498688 [TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling. Huang SW; Lien JC; Kuo SC; Huang TF Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611 [TBL] [Abstract][Full Text] [Related]
5. Chlorogenic acid inhibits hypoxia-induced angiogenesis via down-regulation of the HIF-1α/AKT pathway. Park JJ; Hwang SJ; Park JH; Lee HJ Cell Oncol (Dordr); 2015 Apr; 38(2):111-8. PubMed ID: 25561311 [TBL] [Abstract][Full Text] [Related]
6. AT-533, a novel Hsp90 inhibitor, inhibits breast cancer growth and HIF-1α/VEGF/VEGFR-2-mediated angiogenesis in vitro and in vivo. Zhang PC; Liu X; Li MM; Ma YY; Sun HT; Tian XY; Wang Y; Liu M; Fu LS; Wang YF; Chen HY; Liu Z Biochem Pharmacol; 2020 Feb; 172():113771. PubMed ID: 31863779 [TBL] [Abstract][Full Text] [Related]
7. Total Flavones of Abelmoschus manihot Exhibits Pro-Angiogenic Activity by Activating the VEGF-A/VEGFR2-PI3K/Akt Signaling Axis. Zhu GS; Tang LY; Lv DL; Jiang M Am J Chin Med; 2018; 46(3):567-583. PubMed ID: 29595071 [TBL] [Abstract][Full Text] [Related]
8. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment. De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519 [TBL] [Abstract][Full Text] [Related]
9. Selenadiazole Derivatives Inhibit Angiogenesis-Mediated Human Breast Tumor Growth by Suppressing the VEGFR2-Mediated ERK and AKT Signaling Pathways. Lai H; Fu X; Sang C; Hou L; Feng P; Li X; Chen T Chem Asian J; 2018 Jun; 13(11):1447-1457. PubMed ID: 29575811 [TBL] [Abstract][Full Text] [Related]
10. Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis. Bi YL; Mi PY; Zhao SJ; Pan HM; Li HJ; Liu F; Shao LR; Zhang HF; Zhang P; Jiang SL Int J Mol Med; 2017 May; 39(5):1255-1261. PubMed ID: 28358414 [TBL] [Abstract][Full Text] [Related]
11. Jianpi Jiedu decoction, a traditional Chinese medicine formula, inhibits tumorigenesis, metastasis, and angiogenesis through the mTOR/HIF-1α/VEGF pathway. Peng W; Zhang S; Zhang Z; Xu P; Mao D; Huang S; Chen B; Zhang C; Zhang S J Ethnopharmacol; 2018 Oct; 224():140-148. PubMed ID: 29852266 [TBL] [Abstract][Full Text] [Related]
12. Ascofuranone suppresses EGF-induced HIF-1α protein synthesis by inhibition of the Akt/mTOR/p70S6K pathway in MDA-MB-231 breast cancer cells. Jeong YJ; Cho HJ; Magae J; Lee IK; Park KG; Chang YC Toxicol Appl Pharmacol; 2013 Dec; 273(3):542-50. PubMed ID: 24096035 [TBL] [Abstract][Full Text] [Related]
13. High-Mobility Group Box 1 (HMGB1) Promotes Angiogenesis and Tumor Migration by Regulating Hypoxia-Inducible Factor 1 (HIF-1α) Expression via the Phosphatidylinositol 3-Kinase (PI3K)/AKT Signaling Pathway in Breast Cancer Cells. He H; Wang X; Chen J; Sun L; Sun H; Xie K Med Sci Monit; 2019 Apr; 25():2352-2360. PubMed ID: 30930461 [TBL] [Abstract][Full Text] [Related]
14. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway. Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437 [TBL] [Abstract][Full Text] [Related]
15. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling. Navone SE; Guarnaccia L; Cordiglieri C; Crisà FM; Caroli M; Locatelli M; Schisano L; Rampini P; Miozzo M; La Verde N; Riboni L; Campanella R; Marfia G World Neurosurg; 2018 Dec; 120():e380-e391. PubMed ID: 30144594 [TBL] [Abstract][Full Text] [Related]
16. Genistein potentiates Centchroman induced antineoplasticity in breast cancer via PI3K/Akt deactivation and ROS dependent induction of apoptosis. Kaushik S; Shyam H; Agarwal S; Sharma R; Nag TC; Dwivedi AK; Balapure AK Life Sci; 2019 Dec; 239():117073. PubMed ID: 31751581 [TBL] [Abstract][Full Text] [Related]
17. Rhein inhibits angiogenesis and the viability of hormone-dependent and -independent cancer cells under normoxic or hypoxic conditions in vitro. Fernand VE; Losso JN; Truax RE; Villar EE; Bwambok DK; Fakayode SO; Lowry M; Warner IM Chem Biol Interact; 2011 Jul; 192(3):220-32. PubMed ID: 21457705 [TBL] [Abstract][Full Text] [Related]
18. Centchroman prevents metastatic colonization of breast cancer cells and disrupts angiogenesis via inhibition of RAC1/PAK1/β-catenin signaling axis. Khan S; Shukla S; Farhan M; Sinha S; Lakra AD; Penta D; Kannan A; Meeran SM Life Sci; 2020 Sep; 256():117976. PubMed ID: 32561397 [TBL] [Abstract][Full Text] [Related]
19. Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways. Shen K; Ji L; Gong C; Ma Y; Yang L; Fan Y; Hou M; Wang Z Biochem Pharmacol; 2012 Sep; 84(6):784-92. PubMed ID: 22771629 [TBL] [Abstract][Full Text] [Related]
20. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling. Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]